病理装置の世界市場

病理装置の世界市場は2030年までに81億米ドルに達する見込み

2024年に60億米ドルと推定される病理装置の世界市場は、2024～2030年の分析期間にCAGR 5.1%で成長し、2030年には81億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである臨床化学技術は、CAGR 6.0%を記録し、分析期間終了時には33億米ドルに達すると予測されます。免疫測定技術分野の成長率は、分析期間中CAGR 5.7%と推定されます。

米国市場は16億米ドルと推定、中国はCAGR 9.3％で成長予測

米国の病理装置市場は、2024年に16億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに17億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.1％と4.0％と予測されています。欧州では、ドイツがCAGR 3.0%で成長すると予測されています。

世界の病理装置市場- 主要動向と促進要因のまとめ

精密診断の需要に応えるため、病理装置はどのように進歩しているのか？

病理装置は医療診断エコシステムの最前線に位置し、疾患検出、分類、治療モニタリングのバックボーンとして機能しています。精密医療、低侵襲診断、早期疾患特定へのシフトは、病理組織検査装置、細胞診システム、免疫組織化学プラットフォーム、デジタル病理スキャナー、自動スライドプロセッサーなど、さまざまな病理検査装置に革新を促しています。これらのツールは、ハイスループット、再現性、分析感度の高い検査ワークフローを実現する上で不可欠な役割を果たしています。

病理組織学的検査は、がんの診断や病期分類におけるゴールドスタンダードであり続けているため、自動組織プロセッサー、ミクロトーム、包埋センター、染色システムに対する需要は、これまで以上に重要になっています。液状細胞診（LBC）システムや自動スライド作製装置などの細胞診装置は、特に子宮頸がんや呼吸器がんを対象としたがん検診プログラムで人気を集めています。一方、免疫組織化学（IHC）は、腫瘍学におけるバイオマーカー検出のために大きく採用されており、抗体ベースの染色システムは、一貫性と拡張性のためにラボの自動化チェーンに統合されています。

さらに、デジタルパソロジーの出現は、スライドベースの診断をアナログから画像中心のプラットフォームへと変化させています。ホールスライドイメージング（WSI）装置は、従来のガラススライドを高解像度のデジタルフォーマットに変換し、それをAIを搭載したソフトウェアで解析し、細胞形態、腫瘍のグレーディング、異常の検出を行う。このデジタル化により、病理医間の遠隔コラボレーションが可能になり、観察者間のばらつきが減少し、サービスが行き届いていない地方での遠隔病理診断がサポートされます。病院が統合ヘルスケアシステムに統合されるにつれて、病理検査装置の相互運用性と集中診断の需要は増加の一途をたどっています。

従来の病理ワークフローを破壊する技術革新とは？

デジタルトランスフォーメーションは、従来のワークフローにイメージング、アナリティクス、クラウドインフラストラクチャを統合することで、病理検査装置の状況を再定義しています。40倍の倍率で画像を撮影できるホールスライドスキャナーは、高速オートフォーカス、深さ解像度のためのZスタッキング、大量のサンプルに対応するバッチスキャン機能を搭載するようになってきています。これらの装置は、AI/MLアルゴリズムによって補完され、組織の特徴の定量化、潜在的な異常のフラグ立て、自動診断提案の生成などを支援し、病理医の意思決定プロセスを合理化します。

自動化はもう一つの重要なディスラプターです。試薬やプロトコルを自動選択するスマート染色プラットフォームに至るまで、病理検査室は手作業による介入を最小限に抑え、所要時間とエラー率を削減しています。モジュラーラボオートメーションシステムは、現在、サンプルトラッキング、バーコードリーダー、リキッドハンドラー、スライドカバースリッパーをシームレスな診断パイプラインにリンクし、ラボが診断精度を損なうことなく、より速いスループットを達成することを可能にします。臨床検査情報システム（LIS）との統合により、リアルタイムの追跡、コンプライアンス、報告の効率化がさらに確実なものとなります。

さらに、コンパニオン診断薬の台頭は装置開発にも影響を与えています。製薬会社と診断薬メーカーが協力して、組織ベースのバイオマーカー検証をサポートする病理学的プラットフォームを構築し、標的治療や個別化腫瘍治療を可能にしています。マルチプレックスIHCとin situハイブリダイゼーション（ISH）ツールは、検査室が1枚のスライドで複数のバイオマーカーを検出するのに役立っており、組織サンプルを節約しながら診断収率を高めています。また、これらの技術はFDAやCEマーキングの枠組みで規制遵守の検証も行われており、世界中で臨床展開が可能になっています。

病理装置の需要を牽引しているエンドユーザーと地域市場は？

病理装置の主なエンドユーザーは、病院、診断基準検査室、学術医療センター、がん研究機関です。大規模な病院チェーンでは、生検量の増加に対応し、レポート作成期間を短縮し、病理マンパワーを最適化するために、自動病理検査プラットフォームの導入が急速に進んでいます。複数のヘルスケアプロバイダーの検査を処理する中央ラボでは、効率を高め、遠隔診察を可能にするために、ロボットやデジタル病理学ソリューションへの投資が増加しています。

学術機関やがんセンターは、特にAI判読や多重免疫組織化学を含む次世代装置の早期導入において重要な役割を果たしています。これらのセンターは、新興技術の検証ハブとして機能し、臨床や規制当局の承認に必要なエビデンスベースに貢献することが多いです。さらに、製薬会社の研究開発や医薬品開発業務受託機関（CRO）は、バイオマーカースクリーニングや薬効試験にデジタル病理プラットフォームを採用しており、非臨床市場の成長をもたらしています。

地域別では、北米と西欧が、高度なヘルスケアインフラ、生検量の多さ、病理学に基づく診断に対する支援的な償還により、依然として優位を保っています。特に米国では、CMSの政策やFDAのデジタル画像ガイドラインが好感され、病理検査室の統合やデジタル病理検査の普及が進んでいます。一方、中国、インド、韓国を筆頭とするアジア太平洋では、がん検診プログラムの拡大や官民診断チェーンの事業拡大に伴い、病理インフラが急成長しています。ラテンアメリカと中東は、三次医療とがん診断への投資が装置導入の新たな道を開いている新興市場です。

病理装置世界市場の成長を促進する要因は？

世界の病理装置市場の成長は、慢性疾患や腫瘍性疾患の有病率の増加、早期かつ正確な診断に対する需要、デジタル病理学やラボの自動化における進歩、個別化医療に向けた世界の推進力によってもたらされます。がん罹患率の上昇、人口の高齢化、予防医療に対する意識の高まりにより、診断システムには迅速で再現性が高く、実用的な結果を出すことが求められており、これが先進的な病理装置の需要を促進しています。

世界中のヘルスケアシステムは、訓練を受けた病理医の不足に対処し、検体から報告までの時間を短縮し、診断の質を向上させるために、集中化されデジタル化された病理学プラットフォームを採用しています。これと並行して、病理学と分子診断学およびAIアナリティクスとの統合が進み、臨床医は組織サンプルからより深い洞察を引き出すことができるようになり、個別化された治療計画への道が開かれつつあります。これらの要因は、治療効果が正確な腫瘍分類とバイオマーカーの状態によって左右されることが多い腫瘍学に特に関連しています。

さらに、医療装置企業、ベンチャーキャピタル、ヘルスケアIT企業からの強力な投資が、技術革新と商業化を加速させています。診断ラボ、ハイテク企業、製薬企業間の共同開発により、次世代ヘルスケアに適したソリューションが生み出されています。デジタル病理装置の承認や柔軟な臨床試験要件などの規制の進歩により、参入障壁がさらに取り除かれつつあります。デジタル医療と精密医療が融合する中、病理装置は現代の診断に不可欠なものとなり、世界市場の力強く持続的な拡大を牽引します。

セグメント

技術（臨床化学、免疫測定、微生物学、分子診断、その他技術）、用途（創薬・開発、疾病診断、法医学診断、その他用途）、エンドユーザー（製薬企業、病院・診断ラボ、その他エンドユーザー）

調査対象企業の例

• 3DHISTECH
• Abbott Laboratories
• Agilent Technologies
• Beckman Coulter（Danaher）
• Becton, Dickinson and Company（BD）
• Bio-Rad Laboratories
• CellaVision
• ContextVision
• Danaher Corporation
• Epredia（3DHISTECH）
• F. Hoffmann-La Roche AG
• Hamamatsu Photonics
• Hamamatsu Photonics
• Leica Biosystems（Danaher）
• Mikroscan Technologies
• Olympus Corporation
• Ortho-Clinical Diagnostics
• PerkinElmer
• PHC Holdings/Sakura Finetek
• Philips（Digital Pathology）

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Pathology Devices Market to Reach US$8.1 Billion by 2030

The global market for Pathology Devices estimated at US$6.0 Billion in the year 2024, is expected to reach US$8.1 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Clinical Chemistry Technology, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Immunoassays Technology segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 9.3% CAGR

The Pathology Devices market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 4.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Pathology Devices Market - Key Trends & Drivers Summarized

How Are Pathology Devices Advancing to Meet the Demands of Precision Diagnostics?

Pathology devices are at the forefront of the medical diagnostics ecosystem, serving as the backbone of disease detection, classification, and therapeutic monitoring. The shift toward precision medicine, minimally invasive diagnostics, and early disease identification is driving innovation across a range of pathology instrumentation, including histopathology equipment, cytology systems, immunohistochemistry platforms, digital pathology scanners, and automated slide processors. These tools play an indispensable role in enabling high-throughput, reproducible, and analytically sensitive laboratory workflows.

Histopathological examination remains the gold standard in cancer diagnostics and disease staging, making the demand for automated tissue processors, microtomes, embedding centers, and staining systems more critical than ever. Cytology devices, including liquid-based cytology (LBC) systems and automated slide preparers, are gaining traction in cancer screening programs, particularly for cervical and respiratory tract cancers. Immunohistochemistry (IHC), meanwhile, has seen significant adoption for biomarker detection in oncology, with antibody-based staining systems being integrated into lab automation chains for consistency and scalability.

Moreover, the advent of digital pathology is transforming slide-based diagnostics from analog to image-centric platforms. Whole-slide imaging (WSI) devices convert traditional glass slides into high-resolution digital formats, which are then analyzed via AI-powered software for cell morphology, tumor grading, and anomaly detection. This digital transition is enabling remote collaboration between pathologists, reducing inter-observer variability, and supporting telepathology for underserved and rural regions. As hospitals consolidate into integrated healthcare systems, the demand for pathology device interoperability and centralized diagnostics continues to rise.

What Technology Innovations Are Disrupting Traditional Pathology Workflows?

Digital transformation is redefining the pathology device landscape by integrating imaging, analytics, and cloud infrastructure into conventional workflows. Whole-slide scanners, capable of capturing images at 40x magnification, are increasingly equipped with high-speed autofocus, z-stacking for depth resolution, and batch scanning capabilities for large sample volumes. These devices are complemented by AI/ML algorithms that assist in quantifying tissue features, flagging potential abnormalities, and generating automated diagnostic suggestions-streamlining the pathologist’s decision-making process.

Automation is another key disruptor. From robotic arms used in sample accessioning to smart staining platforms that auto-select reagents and protocols, pathology labs are minimizing manual intervention to reduce turnaround time and error rates. Modular lab automation systems now link sample tracking, barcode readers, liquid handlers, and slide cover-slippers into a seamless diagnostic pipeline, allowing laboratories to achieve faster throughput without compromising diagnostic accuracy. Integration with Laboratory Information Systems (LIS) further ensures real-time tracking, compliance, and reporting efficiency.

Additionally, the rise of companion diagnostics is influencing device development. Pharmaceutical companies and diagnostics manufacturers are collaborating to build pathology platforms that support tissue-based biomarker validation, enabling targeted therapies and personalized oncology treatments. Multiplex IHC and in situ hybridization (ISH) tools are helping laboratories detect multiple biomarkers on a single slide, increasing diagnostic yield while conserving tissue samples. These technologies are also being validated for regulatory compliance under FDA and CE marking frameworks, making them viable for clinical deployment worldwide.

Which End-Use Settings and Regional Markets Are Driving Demand for Pathology Devices?

Hospitals, diagnostic reference laboratories, academic medical centers, and cancer research institutions represent the primary end-users of pathology devices. Large hospital chains are rapidly adopting automated pathology platforms to accommodate growing biopsy volumes, shorten reporting timelines, and optimize pathology manpower. Centralized labs that process tests for multiple healthcare providers are increasingly investing in robotic and digital pathology solutions to boost efficiency and enable remote consultations.

Academic institutions and cancer centers play a critical role in the early adoption of next-generation devices, particularly those involving AI interpretation and multiplex immunohistochemistry. These centers often serve as validation hubs for emerging technologies and contribute to the evidence base required for clinical and regulatory approvals. Additionally, pharmaceutical R&D and contract research organizations (CROs) are adopting digital pathology platforms for biomarker screening and drug efficacy trials-creating a growing non-clinical market for pathology devices.

Regionally, North America and Western Europe remain dominant due to advanced healthcare infrastructure, high biopsy volumes, and supportive reimbursement for pathology-based diagnostics. The U.S., in particular, is witnessing consolidation of pathology labs and strong uptake of digital pathology due to favorable CMS policies and FDA's digital imaging guidelines. Meanwhile, Asia-Pacific-led by China, India, and South Korea-is experiencing rapid growth in pathology infrastructure as cancer screening programs expand and public-private diagnostic chains scale up operations. Latin America and the Middle East are emerging markets where investments in tertiary care and cancer diagnosis are opening up new pathways for device adoption.

What Factors Are Driving the Growth of the Global Pathology Devices Market?

The growth in the global pathology devices market is driven by the increasing prevalence of chronic and oncological diseases, demand for early and accurate diagnostics, advancements in digital pathology and lab automation, and the global push toward personalized medicine. With rising cancer incidence, aging populations, and greater awareness about preventive health, there is growing pressure on diagnostic systems to deliver fast, reproducible, and actionable results-propelling the demand for advanced pathology devices.

Healthcare systems worldwide are adopting centralized and digitized pathology platforms to address shortages of trained pathologists, reduce sample-to-report time, and improve diagnostic quality. In parallel, the integration of pathology with molecular diagnostics and AI analytics is enabling clinicians to extract deeper insights from tissue samples, paving the way for personalized therapy plans. These factors are particularly relevant in oncology, where treatment efficacy often depends on precise tumor classification and biomarker status.

Furthermore, strong investments from medical device firms, venture capitalists, and healthcare IT companies are accelerating innovation and commercialization. Collaborations between diagnostic labs, tech companies, and pharma players are resulting in co-developed solutions tailored for next-generation healthcare. Regulatory advancements, such as digital pathology device approvals and flexible clinical trial requirements, are further removing entry barriers. As digital and precision medicine converge, pathology devices are set to become indispensable to modern diagnostics, driving strong and sustained global market expansion.

SCOPE OF STUDY:

The report analyzes the Pathology Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology, Other Technologies); Application (Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application, Other Applications); End-User (Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

• 3DHISTECH
• Abbott Laboratories
• Agilent Technologies
• Beckman Coulter (Danaher)
• Becton, Dickinson and Company (BD)
• Bio-Rad Laboratories
• CellaVision
• ContextVision
• Danaher Corporation
• Epredia (3DHISTECH)
• F. Hoffmann-La Roche AG
• Hamamatsu Photonics
• Hamamatsu Photonics
• Leica Biosystems (Danaher)
• Mikroscan Technologies
• Olympus Corporation
• Ortho-Clinical Diagnostics
• PerkinElmer
• PHC Holdings / Sakura Finetek
• Philips (Digital Pathology)

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Pathology Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Global Cancer Burden Throws the Spotlight on Advanced Pathology Diagnostic Equipment
  • Automation and Digital Pathology Trends Drive Demand for High-Throughput Devices
  • Integration of Artificial Intelligence in Histopathology Spurs Workflow Efficiency and Accuracy
  • Expansion of Precision Medicine and Molecular Diagnostics Strengthens Business Case for Pathology Platforms
  • Increased Adoption of Digital Slide Scanners and Image Analysis Systems Propels Market Growth
  • Growth in Biopsy Testing and Early Disease Detection Accelerates Use of Specialized Pathology Instruments
  • Integration of LIS and EMR Systems Enhances Data Interoperability for Pathology Labs
  • Global Shortage of Pathologists Promotes Use of AI-Driven Diagnostic Devices
  • Demand for Remote Pathology and Telemedicine Platforms Expands Use of Digital Diagnostic Equipment
  • Government Funding for Cancer Screening and Laboratory Modernization Supports Market Penetration
  • Regulatory Approvals for AI-Based Diagnostic Algorithms Spur Commercialization of Smart Devices
  • Advancements in Multi-Modality Imaging and Staining Technologies Enhance Device Functionality
  • Rising Geriatric Population Drives Screening Volume for Age-Linked Diseases and Tumors
  • Focus on Lab Efficiency and Turnaround Time Reductions Fuels High-Speed Device Adoption
  • Increased Sample Volume in Oncology and Infectious Disease Diagnostics Boosts Equipment Demand
  • Growth in Clinical Research and Biobank Development Expands Pathology Device Applications
  • Emergence of Integrated Pathology Workstations Optimizes End-to-End Diagnostic Workflows
  • Market Consolidation Among Device Manufacturers Spurs Innovation Through Strategic Acquisitions
  • Customization and Scalability Requirements Propel Demand for Modular Pathology Systems
  • Stringent Quality Control and Accreditation Norms Drive Adoption of Standardized Diagnostic Equipment
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pathology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pathology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Immunoassays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Microbiology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Pharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Pharmaceutical Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Pharmaceutical Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals & Diagnostic Laboratories End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Hospitals & Diagnostic Laboratories End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Disease Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Disease Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Forensic Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Forensic Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Forensic Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Canada 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• JAPAN
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Japan 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Japan 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• CHINA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: China 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: China 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• EUROPE
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Pathology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Europe 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Europe 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• FRANCE
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: France 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: France 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• GERMANY
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Germany 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Germany 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Italy 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Italy 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: UK 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: UK 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Spain 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Spain 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Russia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Russia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Pathology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Australia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Australia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• INDIA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: India 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: India 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: South Korea 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: South Korea 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Pathology Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Latin America 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Latin America 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Argentina 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Argentina 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Brazil 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Brazil 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Mexico 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Mexico 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Pathology Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Pathology Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Middle East 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Middle East 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Iran 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Iran 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Israel 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Israel 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: UAE 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: UAE 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030
• AFRICA
  • Pathology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Pathology Devices by Technology - Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Pathology Devices by Technology - Percentage Breakdown of Value Sales for Clinical Chemistry Technology, Immunoassays Technology, Microbiology Technology, Molecular Diagnostics Technology and Other Technologies for the Years 2014, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Pathology Devices by End-user - Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Africa 16-Year Perspective for Pathology Devices by End-user - Percentage Breakdown of Value Sales for Pharmaceutical Companies End-User, Hospitals & Diagnostic Laboratories End-User and Other End-Users for the Years 2014, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Pathology Devices by Application - Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Africa 16-Year Perspective for Pathology Devices by Application - Percentage Breakdown of Value Sales for Drug Discovery & Development Application, Disease Diagnostics Application, Forensic Diagnostics Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION